HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
494.94
-4.71 (-0.94%)
Mar 20, 2026, 11:57 AM EDT - Market open
HCA Healthcare Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$528.00
Upside
+6.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $529 → $561 | Strong Buy | Maintains | $529 → $561 | +13.35% | Mar 10, 2026 |
| Mizuho | Mizuho | Buy Maintains $540 → $585 | Buy | Maintains | $540 → $585 | +18.20% | Feb 25, 2026 |
| UBS | UBS | Strong Buy Maintains $598 → $635 | Strong Buy | Maintains | $598 → $635 | +28.30% | Feb 23, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $420 → $535 | Hold | Maintains | $420 → $535 | +8.10% | Feb 20, 2026 |
| Argus Research | Argus Research | Strong Buy Maintains $530 → $560 | Strong Buy | Maintains | $530 → $560 | +13.15% | Feb 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $452 → $481 | Hold | Maintains | $452 → $481 | -2.82% | Jan 30, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $535 → $590 | Strong Buy | Maintains | $535 → $590 | +19.21% | Jan 28, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $500 → $540 | Buy | Maintains | $500 → $540 | +9.11% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $525 → $555 | Buy | Maintains | $525 → $555 | +12.14% | Jan 28, 2026 |
| UBS | UBS | Strong Buy Maintains $525 → $598 | Strong Buy | Maintains | $525 → $598 | +20.82% | Jan 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $525 → $588 | Buy | Maintains | $525 → $588 | +18.80% | Jan 28, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $520 → $546 | Strong Buy | Maintains | $520 → $546 | +10.32% | Jan 28, 2026 |
| Keybanc | Keybanc | Buy Maintains $500 → $550 | Buy | Maintains | $500 → $550 | +11.13% | Jan 28, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $500 → $558 | Strong Buy | Maintains | $500 → $558 | +12.74% | Jan 28, 2026 |
| Barclays | Barclays | Buy Maintains $494 → $551 | Buy | Maintains | $494 → $551 | +11.33% | Jan 28, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $431 → $452 | Hold | Maintains | $431 → $452 | -8.67% | Jan 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.